retatrutide trials in boston biotech secures Series A funding to move its once-weekly GLP-1 obesity patch into first-in-human clinical trials. ㅤ Link bio. ㅤ #longevity #obesity #glp1 #clinicaltrials #biotech Eli Lilly touts strong results

But Eimer emphasized that the findings should not discourage appropriate use of GLP-1 drugs, which have become increasingly popular for treating diabetes, obesity, cardiovascular disease and sleep apnea

Can I track GLP-1 side effects like nausea or constipation

The challenges of weight management on semaglutide and the strategies for maintaining results are important considerations when weighing the decision to continue or stop treatment

Another notable transcript upregulated in the -1 subcluster in response to liraglutide treatment was somatostatin ( SST ) (Figure 4B)

Our program covers everything you need to know about losing weight with weight-loss medication and maintaining your goals once you've stopped medication